Literature DB >> 33174070

The role of sirt1 in the retinal ganglion cells cultured by high glucose.

Yue Zhou1,2, Lian-Jun Cai1, Li-Hui Xu1, Yu Guo1, Nuo Chen3, Qing Yao4.   

Abstract

OBJECTIVE: To observe the effect of sirt1 on retinal ganglion cells (RGC) with high glucose culture and to explore the role of sirt1 in the development of diabetic retinopathy. Method RGC was infected by sirt1 lentivirus overexpression vector pLV5-sirt1 and interference vector pLV3-si-sirt1. The normal control group and control virus vector group were set up at the same time. After 48 h of infection, the viability of RGC was detected by CCK8 kit, the apoptosis rate was detected by FCM analysis, and the protein expression of p53, FOXO3a, NF-κ B, caspase-3 was detected by Western blot.
RESULTS: After RGC were infected with lentivirus, the cell viability of lentivirus overexpression vector pLV5-sirt1 was significantly higher than that of the high glucose group and the sirt1 overexpression control group, while the cell viability of interference vector pLV3-si-sirt1 was significantly lower than that of the high glucose group and the sirt1 interference control group (P < 0.05). At the same time, the apoptosis rate of RGC cells infected by lentivirus overexpression vector pLV5-sirt1 was lower than that of the high glucose group and the control virus vector group, while the apoptosis rate of the interference vector pLV3-si-sirt1 cells was significantly higher than that of the high glucose group and the control virus vector group (P < 0.05). The results of Western blotting showed that the expression of p53, FOXO3a, NF-κ B and caspase-3 in RGC cells decreased significantly after infection with pLV5-sirt1 compared with the high glucose group and the control virus vector group, while the expression of p53, FOXO3a, NF-κB and caspase-3 in RGC cells increased significantly after infection with pLV3-si-sirt1 (P < 0.05).
CONCLUSION: Sirt1 can inhibit the apoptosis of RGCs through regulating the expression of some apoptotic cytokinessome, and it can be used as a candidate gene for the biotherapy of retinal diseases.

Entities:  

Keywords:  Diabetic retinopathy; Retinal ganglion cells; Sirt1

Mesh:

Substances:

Year:  2020        PMID: 33174070     DOI: 10.1007/s10792-020-01638-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  2 in total

1.  Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1.

Authors:  Susanne Voelter-Mahlknecht; Ulrich Mahlknecht
Journal:  Int J Mol Med       Date:  2006-01       Impact factor: 4.101

2.  Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy.

Authors:  Michael A Grassi; Wanjie Sun; Sapna Gangaputra; Patricia A Cleary; Larry Hubbard; John M Lachin; Xiaoyu Gao; Szilárd Kiss; Andrew J Barkmeier; Arghavan Almony; Matthew Davis; Ronald Klein; Ronald P Danis
Journal:  Ophthalmology       Date:  2013-07-24       Impact factor: 12.079

  2 in total
  2 in total

Review 1.  From Bench to Bed: The Current Genome Editing Therapies for Glaucoma.

Authors:  Meihui He; Rong Rong; Dan Ji; Xiaobo Xia
Journal:  Front Cell Dev Biol       Date:  2022-05-16

2.  Sulforaphane ameliorates amyloid-β-induced inflammatory injury by suppressing the PARP1/SIRT1 pathway in retinal pigment epithelial cells.

Authors:  Song Wang; Yu-Jie Tang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.